[go: up one dir, main page]

Miller et al., 2020 - Google Patents

Multiorgan microfluidic platform with breathable lung chamber for inhalation or intravenous drug screening and development

Miller et al., 2020

View PDF
Document ID
7811538618931396601
Author
Miller P
Chen C
Wang Y
Gao E
Shuler M
Publication year
Publication venue
Biotechnology and bioengineering

External Links

Snippet

Efficient and economical delivery of pharmaceuticals to patients is critical for effective therapy. Here we describe a multiorgan (lung, liver, and breast cancer) microphysiological system (“Body‐on‐a‐Chip”) designed to mimic both inhalation therapy and/or intravenous …
Continue reading at analyticalsciencejournals.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types

Similar Documents

Publication Publication Date Title
Miller et al. Multiorgan microfluidic platform with breathable lung chamber for inhalation or intravenous drug screening and development
Novak et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips
US12187997B2 (en) Integrated human organ-on-chip microphysiological systems
Herland et al. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips
Li et al. Microfluidic organ-on-a-chip system for disease modeling and drug development
Prantil-Baun et al. Physiologically based pharmacokinetic and pharmacodynamic analysis enabled by microfluidically linked organs-on-chips
Maoz et al. A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells
Jiang et al. Recent progress in microfluidic models of the blood-brain barrier
Marx et al. Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing
Wang et al. Self-contained, low-cost Body-on-a-Chip systems for drug development
Rogal et al. Integration concepts for multi-organ chips: how to maintain flexibility?!
Ko et al. Engineering organ-on-a-chip to accelerate translational research
Bovard et al. Organs-on-a-chip: A new paradigm for toxicological assessment and preclinical drug development
Yang et al. PBPK modeling on organs-on-chips: an overview of recent advancements
Malik et al. Critical considerations for the design of multi-organ microphysiological systems (MPS)
Rothbauer et al. A decade of organs-on-a-chip emulating human physiology at the microscale: a critical status report on progress in toxicology and pharmacology
US10927335B2 (en) Microfluidic body-on-a-chip device and methods of use thereof
Palaninathan et al. Multi-organ on a chip for personalized precision medicine
Jain et al. Organ-on-a-chip and 3D printing as preclinical models for medical research and practice
Li et al. Advances of 3D Cell Co-Culture Technology Based on Microfluidic Chips
Ponmozhi et al. Models for barrier understanding in health and disease in lab-on-a-chips
Man et al. Organoids‐On‐a‐Chip for Personalized Precision Medicine
Yuan et al. Revolutionizing Drug Discovery: The Impact of Distinct Designs and Biosensor Integration in Microfluidics-Based Organ-on-a-Chip Technology
Zhang Organ-on-a-chip
Tian et al. Organ chips and visualization of biological systems